177 related articles for article (PubMed ID: 34682823)
1. Fecal Levels of Lactic, Succinic and Short-Chain Fatty Acids in Patients with Ulcerative Colitis and Crohn Disease: A Pilot Study.
Kaczmarczyk O; Dąbek-Drobny A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Piątek-Guziewicz A; Zagrodzki P; Mach T; Zwolińska-Wcisło M
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682823
[TBL] [Abstract][Full Text] [Related]
2. Association between Fecal Short-Chain Fatty Acid Levels, Diet, and Body Mass Index in Patients with Inflammatory Bowel Disease.
Dąbek-Drobny A; Kaczmarczyk O; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Piątek-Guziewicz A; Zagrodzki P; Zwolińska-Wcisło M
Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053106
[TBL] [Abstract][Full Text] [Related]
3. Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects.
Ozturk O; Celebi G; Duman UG; Kupcuk E; Uyanik M; Sertoglu E
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):890-896. PubMed ID: 38829943
[TBL] [Abstract][Full Text] [Related]
4. Fecal short-chain fatty acids in children with inflammatory bowel disease.
Treem WR; Ahsan N; Shoup M; Hyams JS
J Pediatr Gastroenterol Nutr; 1994 Feb; 18(2):159-64. PubMed ID: 8014762
[TBL] [Abstract][Full Text] [Related]
5. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
6. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
7. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease.
Lemay JA; Yamamoto M; Kroezen Z; Shanmuganathan M; Ly R; Hart L; Pai N; Britz-McKibbin P
J Pharm Biomed Anal; 2021 Jan; 192():113658. PubMed ID: 33091761
[TBL] [Abstract][Full Text] [Related]
8. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
Yao Y; Liu Y; Xu Q; Mao L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
[TBL] [Abstract][Full Text] [Related]
9. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
10. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
12. Organic anions and the diarrhea of inflammatory bowel disease.
Vernia P; Gnaedinger A; Hauck W; Breuer RI
Dig Dis Sci; 1988 Nov; 33(11):1353-8. PubMed ID: 3180970
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
14. Association between fecal levels of Short-Chain Fatty Acids and serum Pro- and Anti-Inflammatory Cytokines in patients with Inflammatory Bowel Disease.
Kaczmarczyk O; Dąbek-Drobny A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Piątek-Guziewicz A; Wcisło K; Zagrodzki P; Zwolińska-Wcisło M
Folia Med Cracov; 2022 Jun; 62(1):43-55. PubMed ID: 36088592
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
[TBL] [Abstract][Full Text] [Related]
16. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease.
Meister D; Ghosh S
World J Gastroenterol; 2005 Dec; 11(47):7466-72. PubMed ID: 16437718
[TBL] [Abstract][Full Text] [Related]
17. Reduced fecal short-chain fatty acids in hispanic children with ulcerative colitis.
Rotondo-Trivette S; Wang B; Luan Y; Fiehn O; Sun F; Michail S
Physiol Rep; 2021 Jul; 9(14):e14918. PubMed ID: 34278738
[TBL] [Abstract][Full Text] [Related]
18. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
19. Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate.
Hove H; Mortensen PB
Dig Dis Sci; 1995 Jun; 40(6):1372-80. PubMed ID: 7781463
[TBL] [Abstract][Full Text] [Related]
20. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
